Celox Medical

Severe traumatic injury is a major worldwide public health issue which causes significant social and economic consequences for societies. The World Health Organization recognises road traffic accidents, suicides and homicides as the three leading causes of injury and violence-related deaths, with uncontrolled post-traumatic bleeding being the leading cause of preventable death, both in civilian life and on the battlefield. A number of national and international initiatives have sought to prevent violence- and trauma-related injuries and to also improve the management of severe bleeds in trauma patients via innovative treatment approaches, educational measures and state-of-the-art clinical practice guidelines. Celox™ Medical, together with our parent company Medtrade, is committed to finding the fastest and most effective ways to stop bleeding, seal wounds and control infection, giving emergency responders the very best chance of saving a life, when faced with the unthinkable. Based in the UK since 1999, Medtrade Products Ltd. is a world-leading product innovator, developer and the manufacturer of the Celox product range. Our Celox Medical team of highly skilled experts have a wealth of knowledge in materials science, regulatory, quality requirements and manufacturing processes, and use this to bring to market ground-breaking innovations that rapidly, safely and effectively treat life-threatening bleeding in pre-hospital emergency situations. The Celox product range includes a selection of haemostats and chest seals for treating life-threatening bleeding, as well as anti-bacterial burns dressings. Celox Academy gives us the opportunity to share our knowledge and experience, ensuring that first-responders receive accredited, certified training in line with international resuscitation standards. We are proud to work in partnership with civilian and military emergency response teams around the world to achieve successful clinical outcomes for millions of people.